Cargando…
Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer: The function of lipid metabolism reprogramming in pancreatic cancer
The pathogenesis of pancreatic cancer involves substantial metabolic reprogramming, resulting in abnormal proliferation of tumor cells. This tumorigenic reprogramming is often driven by genetic mutations, such as activating mutations of the KRAS oncogene and inactivating or deletions of the tumor su...
Autores principales: | Guo, Duancheng, Ye, Longyun, Wu, Weiding, Yu, Xianjun, Jin, Kaizhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326418/ https://www.ncbi.nlm.nih.gov/pubmed/37021976 http://dx.doi.org/10.3724/abbs.2023045 |
Ejemplares similares
-
Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer
por: Zhang, Huiru, et al.
Publicado: (2022) -
Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer
por: Shi, Saimeng, et al.
Publicado: (2023) -
Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer
por: Ye, Longyun, et al.
Publicado: (2022) -
Innate Lymphoid Cells: Emerging Players in Pancreatic Disease
por: Shi, Saimeng, et al.
Publicado: (2022) -
Lipid metabolic reprogramming in cancer cells
por: Beloribi-Djefaflia, S, et al.
Publicado: (2016)